Determinants of low HDL levels in familial combined hyperlipidemia (Q44460212)

3 December 2017

Determinants of low HDL levels in familial combined hyperlipidemia (English)

1 reference

3 December 2017

1 reference

2

Matti Jauhiainen

1 reference

PubMed ID

12777471

3 December 2017

Marja-Riitta Taskinen

series ordinal

4

object named as

Marja-Riitta Taskinen

1 reference

3 December 2017

Aino Soro

1

1 reference

PubMed ID

12777471

3 December 2017

Christian Ehnholm

series ordinal

3

1 reference

3 December 2017

1 June 2003

1 reference

Journal of Lipid Research

3 December 2017

1 reference

3 December 2017

44

1 reference

3 December 2017

1536-1544

1 reference

3 December 2017

8

1 reference

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

3 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Defects of lipoprotein metabolism in familial combined hyperlipidaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

High density lipoproteins and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Atheroprotective mechanisms of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Remodelling of high density lipoproteins by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Phospholipid transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

The role of hepatic lipase in lipoprotein metabolism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Serum phospholipid transfer protein activity and genetic variation of the PLTP gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300069-JLR200

10.1194/JLR.M300069-JLR200

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12777471